Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash flows from operating activities:    
Net loss $ (14,871,000) $ (12,186,000)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 577,000 401,000
Stock option compensation expense 3,894,000 2,851,000
Stock issued to directors, employees and consultants 3,120,000 2,960,000
Stock issued for services 0 333,000
Gain on contingent consideration liability (2,591,000) 0
Change in operating assets and liabilities:    
Receivables (491,000) (235,000)
Prepaid expenses and other current assets 159,000 (109,000)
Other assets (4,000) (29,000)
Accounts payable 1,038,000 (1,081,000)
Deferred revenue (452,000) (451,000)
Net cash used in operating activities (9,621,000) (7,546,000)
Cash flows from investing activities:    
Capital expenditures (501,000) (41,000)
Cash from Abeona Ohio 0 3,697,000
Net cash (used in) provided by investing activities (501,000) 3,656,000
Cash flows from financing activities:    
Proceeds from exercise of $5.00 warrants 0 4,635,000
Proceeds from $2.85 restricted common stock issuance 150,000 0
Payment of short-term debt 0 (400,000)
Net cash provided by financing activities 1,169,000 35,652,000
Net increase (decrease) in cash and cash equivalents (8,953,000) 31,762,000
Cash and cash equivalents at beginning of period 40,138,000 11,520,000
Cash and cash equivalents at end of period 31,185,000 43,282,000
Supplemental disclosure of noncash transactions:    
Shares issued to holders of Abeona Ohio for acquisition 0 31,758,000
Contingent milestones to Abeona Ohio members 0 6,489,000
Licensed technology from Abeona Ohio 0 2,156,000
Shares issued to EB Research Partnership and Epidermolysis Bullosa Medical Research Foundation for licenses 2,452,000 0
$3.00 Common Stock Issuance [Member]    
Cash flows from financing activities:    
Proceeds from common stock issuances net of costs 0 7,001,000
$8.00 Common Stock Issuance [Member]    
Cash flows from financing activities:    
Proceeds from common stock issuances net of costs 0 9,005,000
$5.50 Common Stock Issuance [Member]    
Cash flows from financing activities:    
Proceeds from common stock issuances net of costs 0 15,411,000
$6.44 Common Stock Issuance [Member]    
Cash flows from financing activities:    
Proceeds from common stock issuances net of costs $ 1,019,000 $ 0